Adaptimmune’s Adrian Rawcliffe On Changing Our Relationship With Cancer

  Рет қаралды 45

Life Science Connect

Life Science Connect

Күн бұрын

Adaptimmune’s Tecelra recently became the first TCR cell therapy approved in the US, and CEO Adrian Rawcliffe explains why cell therapies could transform all cancer treatments.
An excerpt from "T-Cells For The Win With Adaptimmune's Adrian Rawcliffe" - check out the full video at www.bioprocess...
---
#businessofbiotech #biopharma #biotech
Subscribe to the podcast:
Apple - podcasts.apple...
Spotify - open.spotify.c...
KZbin - • The Business Of Biotec...

Пікірлер
OS Therapies’ Paul Romness On The Future Of ADCs
16:34
Life Science Connect
Рет қаралды 44
The Cancer Expert: "This Common Food Is Making Cancer Worse!"
1:37:34
The Diary Of A CEO
Рет қаралды 6 МЛН
The Lost World: Living Room Edition
0:46
Daniel LaBelle
Рет қаралды 27 МЛН
Hilarious FAKE TONGUE Prank by WEDNESDAY😏🖤
0:39
La La Life Shorts
Рет қаралды 44 МЛН
Killing cancer with a breakthrough therapy | 60 Minutes Full Episodes
54:43
Biotech Story Time With Tal Zaks, M.D. (Part 2)
54:05
Life Science Connect
Рет қаралды 124
Why Foresite Labs Is Betting On AI/ML To Revolutionize Drug Development
30:52
Life Biosciences’ Successful Partnership With Forge Biologics
32:41
Life Science Connect
Рет қаралды 6
Why Tal Zaks Believes That Innovation Is Driven By Curiosity
18:03
Life Science Connect
Рет қаралды 4
The Lost World: Living Room Edition
0:46
Daniel LaBelle
Рет қаралды 27 МЛН